Analysis of the utility of QuantiFERON-TB gold in tube and measurement of IFNgamma release by peripheral mononuclear cells in response to different mycobacterium antigen in the work-up of patients with uveitis
Makhoul, D.; Mascart, F.; Schandene, L.; Willermain, F.; Caspers, L.
Bulletin de la Societe Belge d'Ophtalmologie 317: 61-62
2011
ISSN/ISBN: 0081-0746 PMID: 21560863 Document Number: 655003
Document emailed within 1 workday
Related Documents
Okimoto, N.; Nanba, F.; Kurihara, T.; Miyashita, N. 2012: The positive response rate with QuantiFERON-TB GOLD In-Tube in patients with Mycobacterium avium complex Kekkaku: 87(4): 337-339Chattree, V.; Khanna, N.; Bisht, V.; Rao, D.N. 2007: Liposomal delivery of Mycobacterium leprae antigen(s) with murabutide and Trat peptide inhibits Fas-mediated apoptosis of peripheral blood mononuclear cells derived from leprosy patients Indian Journal of Biochemistry and Biophysics 44(5): 386-393
Saracino, A.; Scotto, G.; Fornabaio, C.; Martinelli, D.; Faleo, G.; Cibelli, D.; Tartaglia, A.; Di Tullio, R.; Fazio, V.; Prato, R.; Monno, L.; Angarano, G. 2009: QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy new microbiologica 32(4): 369-376
Niepolski, L.; Grzegorzewska, A.E. 2014: A positive test QuantiFERON-TB Gold In-Tube in a patient treated with continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 37(222): 341-343
Chen, Y.X. 1990: Expression of interleukin 2(IL-2) receptor and proliferative response to rIL-2 of peripheral blood mononuclear cells (PBMC) in patients with malignant diseases Zhonghua Zhong Liu Za Zhi 12(4): 281-283
Attanasio, M.; Gori, A.M.; Giusti, B.; Pepe, G.; Comeglio, P.; Brunelli, T.; Prisco, D.; Abbate, R.; Gensini, G.F.; Neri Serneri, G.G. 1998: Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin Thrombosis and Haemostasis 79(5): 959-962
Harada, H.; Takanashi, N.; Tsukada, Y.; Takahashi, M.; Kimura, E.; Terashima, Y.; Nakamura, H.; Takahashi, E.; Hayata, Y. 1989: Detection of a novel antigen (1G12) on the surface of peripheral blood mononuclear cells from cancer patients by a sensitive radioimmunoassay. A possible marker for the early diagnosis of cancer Japanese Journal of Experimental Medicine 59(6): 215-220
Vinante, F.; Krampera, M.; Morosato, L.; Rigo, A.; Romagnani, S.; Pizzolo, G. 1999: Peripheral T lymphocyte cytokine profile (IFNgamma, IL-2, IL-4) and CD30 expression/release during measles infection Haematologica 84(8): 683-689
Kleynhans, L.éa.; Du Plessis, N.; Black, G.F.; Loxton, A.é G.; Kidd, M.; van Helden, P.D.; Walzl, G.; Ronacher, K. 2011: Medroxyprogesterone acetate alters Mycobacterium bovis BCG-induced cytokine production in peripheral blood mononuclear cells of contraceptive users Plos one 6(9): E24639
Cannon, G.W.; Cole, B.C.; Ward, J.R. 1986: Differential effects of in vitro gold sodium thiomalate on the stimulation of human peripheral blood mononuclear cells by Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin Journal of Rheumatology 13(1): 52-57
Ennas, M.G.; Sorio, C.; Greim, R.; Nieddu, M.; Scarpa, A.; Orlandini, S.; Croce, C.M.; Fey, G.H.; Marschalek, R. 1997: The human ALL-1/MLL/HRX antigen is predominantly localized in the nucleus of resting and proliferating peripheral blood mononuclear cells Cancer Research 57(10): 2035-2041
Hasegawa, H.; Ono, S. 1971: An attempt of statistico-mathematical analysis and classification of human peripheral mononuclear cells. 1. Statistical analysis of morphologic features Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 34(5): 537-547
Lin, C.-Y.; Chien, J.-W. 2004: Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome Acta Paediatrica Taiwanica 45(2): 77-80
Zimecki, M.; Stepniak, D.; Szynol, A.; Kruzel, M.L. 2001: Lactoferrin regulates proliferative response of human peripheral blood mononuclear cells to phytohemagglutinin and mixed lymphocyte reaction Archivum Immunologiae et Therapiae Experimentalis 49(2): 147-154
Uchiyama, T.; Kamagata, Y.; Yan, X.J.; Kohno, M.; Yoshioka, M.; Fujikawa, H.; Igarashi, H.; Okubo, M.; Awano, F.; Saito-Taki, T. 1987: Study of the biological activities of toxic shock syndrome toxin-1: II. Induction of the proliferative response and the interleukin 2 production by T cells from human peripheral blood mononuclear cells stimulated with the toxin Clinical and Experimental Immunology 68(3): 638-647
Wang, K.; Chen, L.Y.; Wang, B.; Han, L.Y.; Hou, Y.D. 2006: Phenotype of peripheral blood mononuclear cells derived dendritic cells from patients with chronic hepatitis B Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 20(3): 250-253
Musiani, P.; Aiello, F.B.; Citterio, F.; Maggiano, N.; Larocca, L.M.; Piantelli, M. 1985: Ultrastructural analysis of peripheral blood mononuclear cells in renal allograft recipients Clinical and Experimental Immunology 61(1): 152-159
Johnson, R.P.; Trocha, A.; Yang, L.; Mazzara, G.P.; Panicali, D.L.; Buchanan, T.M.; Walker, B.D. 1991: HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells Journal of Immunology 147(5): 1512-1521
Seitz, M.; Zwicker, M.; Wider, B. 2001: Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment Journal of Rheumatology 28(3): 496-501
Sodhi, A.; Pai, K. 1992: Studies on the release of interleukin-1 (IL-1), tumor necrosis factor (TNF) and lysozyme from human non-adherent mononuclear cells (nMNC) in vitro after treatment with cisplatin and other biological response modifiers Neoplasma 39(4): 211-217